Association of high lipoprotein (a) level with carotid atherosclerosis and all-cause mortality

IF 4.3 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Anthony Matta , Dorota Taraszkiewicz , Pauline Cougoul , Sylvie Lemozy , Jean Ferrières
{"title":"Association of high lipoprotein (a) level with carotid atherosclerosis and all-cause mortality","authors":"Anthony Matta ,&nbsp;Dorota Taraszkiewicz ,&nbsp;Pauline Cougoul ,&nbsp;Sylvie Lemozy ,&nbsp;Jean Ferrières","doi":"10.1016/j.ajpc.2025.101023","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Lipoprotein (a) Lp(a) is a genetically inherited low-density lipoprotein like particle with proinflammatory, prothrombotic and proatherogenic properties. Current guidelines recommend at least one-time measurement of Lp(a) in cardiovascular risk assessment in each adult person’s lifetime.</div></div><div><h3>Aims</h3><div>The present study evaluates the association between exposure to a high circulating level of Lp(a) (≥50mg/dl or ≥125nmol/L) and atherosclerosis and all-cause of death after a very long-term follow-up.</div></div><div><h3>Methods</h3><div>A retrospective analysis was performed on 11,990 subjects admitted to the department of preventive cardiology at Toulouse University Hospital, Rangueil, France and who underwent at least one Lp (a) measurement between September 1995 and December 2023. The living status (alive or dead) of each of study’s participants was assessed by March 2024. The study population was divided into two groups: first, according to Lp (a) level (normal versus high circulating Lp (a) level), and second, according to the living status.</div></div><div><h3>Results</h3><div>High-Lp(a) level group includes 3195 participants. They were significantly more women (47.5 % vs.41.4 %), non-obese (89.1 % vs.84.7 %), sportier (71 % vs. 68.1 %) and normotensive (70.5 % vs. 67.6 %). The adjusted logistic regression on traditional cardiovascular risk factors reveal a positive association between High Lp(a) level and atherogenic findings on doppler ultrasound of carotid arteries [ORa = 1.308;95 %CI(1.182–1.447), <em>p</em> = 0.001]. The all-cause mortality rate was comparable between the two study groups over 13 years of follow-up (7.4 % vs. 8 %). Survival analyses with Kaplan-Meier curves (<em>p</em> = 0.643) and Cox regression [HR = 0.981, 95 %CI (0.844–1.141), <em>p</em> = 0.811] showed no significant difference in survival outcomes.</div></div><div><h3>Conclusion</h3><div>Long-term exposure to high Lp(a) is a predictor for atherosclerotic cardiovascular disease, but not significantly associated with risk of death from any cause.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":"23 ","pages":"Article 101023"},"PeriodicalIF":4.3000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667725000984","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Lipoprotein (a) Lp(a) is a genetically inherited low-density lipoprotein like particle with proinflammatory, prothrombotic and proatherogenic properties. Current guidelines recommend at least one-time measurement of Lp(a) in cardiovascular risk assessment in each adult person’s lifetime.

Aims

The present study evaluates the association between exposure to a high circulating level of Lp(a) (≥50mg/dl or ≥125nmol/L) and atherosclerosis and all-cause of death after a very long-term follow-up.

Methods

A retrospective analysis was performed on 11,990 subjects admitted to the department of preventive cardiology at Toulouse University Hospital, Rangueil, France and who underwent at least one Lp (a) measurement between September 1995 and December 2023. The living status (alive or dead) of each of study’s participants was assessed by March 2024. The study population was divided into two groups: first, according to Lp (a) level (normal versus high circulating Lp (a) level), and second, according to the living status.

Results

High-Lp(a) level group includes 3195 participants. They were significantly more women (47.5 % vs.41.4 %), non-obese (89.1 % vs.84.7 %), sportier (71 % vs. 68.1 %) and normotensive (70.5 % vs. 67.6 %). The adjusted logistic regression on traditional cardiovascular risk factors reveal a positive association between High Lp(a) level and atherogenic findings on doppler ultrasound of carotid arteries [ORa = 1.308;95 %CI(1.182–1.447), p = 0.001]. The all-cause mortality rate was comparable between the two study groups over 13 years of follow-up (7.4 % vs. 8 %). Survival analyses with Kaplan-Meier curves (p = 0.643) and Cox regression [HR = 0.981, 95 %CI (0.844–1.141), p = 0.811] showed no significant difference in survival outcomes.

Conclusion

Long-term exposure to high Lp(a) is a predictor for atherosclerotic cardiovascular disease, but not significantly associated with risk of death from any cause.
高脂蛋白(a)水平与颈动脉粥样硬化和全因死亡率的关系
脂蛋白(a)是一种遗传的低密度脂蛋白样颗粒,具有促炎、促血栓和促动脉粥样硬化特性。目前的指南建议在每个成年人的一生中,在心血管风险评估中至少测量一次Lp(a)。目的:本研究通过非常长期的随访,评估暴露于高循环水平脂蛋白(a)(≥50mg/dl或≥125nmol/L)与动脉粥样硬化和全死因之间的关系。方法回顾性分析1995年9月至2023年12月在法国兰格埃尔图卢兹大学医院预防心内科接受至少1次Lp (a)测量的11990例患者的资料。到2024年3月,对每个研究参与者的生活状态(活着或死了)进行了评估。将研究人群分为两组:第一组根据血液中脂蛋白(a)水平(正常与高循环脂蛋白(a)水平),第二组根据生活状况。结果高循环脂蛋白(a)水平组3195人。其中女性(47.5%对41.4%)、非肥胖者(89.1%对84.7%)、运动型(71%对68.1%)和血压正常者(70.5%对67.6%)明显更多。对传统心血管危险因素进行调整后的logistic回归分析显示,高脂蛋白(a)水平与颈动脉多普勒超声显示的动脉粥样硬化呈正相关[ORa = 1.308; 95% CI(1.182-1.447), p = 0.001]。在13年的随访中,两个研究组的全因死亡率具有可比性(7.4%对8%)。Kaplan-Meier曲线生存分析(p = 0.643)和Cox回归分析[HR = 0.981, 95% CI (0.844-1.141), p = 0.811]显示两组患者的生存结局无显著差异。结论:长期暴露于高Lp(a)是动脉粥样硬化性心血管疾病的预测因子,但与任何原因导致的死亡风险均无显著相关性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of preventive cardiology
American journal of preventive cardiology Cardiology and Cardiovascular Medicine
CiteScore
6.60
自引率
0.00%
发文量
0
审稿时长
76 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信